Study of Continuous Infusion of Cloxacillin Using Elastomeric Pump in Adult Patients with Staphylococcus Aureus Infection

3 1 1 1

What is this study about?

This study focuses on patients with Staphylococcus aureus infection, which is a serious bacterial infection that can affect various parts of the body. The study will evaluate a treatment using cloxacillin, an antibiotic medication that fights bacterial infections. The medication will be given through continuous delivery into a vein using a special pump device called an elastomeric pump, which provides a steady flow of medication over time.

The purpose of the study is to check whether giving cloxacillin through continuous infusion maintains proper levels of the medication in the blood. This is important to ensure that patients receive enough medication to fight the infection without getting too much that could cause harmful effects. The study will monitor the amount of active medication in the blood at different times during treatment.

During the study, patients will receive cloxacillin continuously through the pump for up to 6 weeks. Blood samples will be taken at several points during the first two days of treatment to measure medication levels. The total daily dose of medication will be between 6 and 12 grams, delivered steadily throughout each 24-hour period.

1 Starting continuous infusion treatment

Your doctor will transition your treatment from regular infusions to a continuous infusion using a device called an elastomeric pump

The medication cloxacillin will be administered at a dose of 6-12 grams over 24 hours

This medication is used to treat infections caused by Staphylococcus aureus bacteria

2 First blood sample collection

A blood sample will be taken at the start of your continuous infusion

This sample helps measure the initial levels of cloxacillin in your blood

3 4-hour check

A second blood sample will be collected approximately 4 hours after starting the continuous infusion

This sample measures how the medication levels have stabilized in your blood

4 24-hour check

A third blood sample will be taken approximately 24 hours after starting the continuous infusion

This helps monitor how your body maintains medication levels over a full day

5 48-hour check

A final blood sample will be collected approximately 48 hours after starting the continuous infusion

This sample completes the monitoring of medication levels in your blood

Who Can Join the Study?

Patient must be 18 years of age or older
Patient’s doctor must determine they are suitable to switch from regular intermittent antibiotic doses to continuous infusion of cloxacillin (an antibiotic medication) using an elastomeric pump (a small, portable device that delivers medication continuously)
Patient must be able to understand and sign an informed consent form to participate in the study
Both male and female patients can participate
Patient must be receiving a daily dose of 6-12 grams of cloxacillin for their infection

Who Cannot Join the Study?

Age below 18 years or above 65 years
Known allergic reactions to cloxacillin or other similar antibiotics
Severe kidney problems (as this may affect how the medication is processed in your body)
Severe liver problems (as this may affect how the medication is processed in your body)
Currently pregnant or breastfeeding
Having a blood infection caused by bacteria other than Staphylococcus aureus
Currently participating in another clinical trial
Unable to understand or follow study instructions
Having an elastomeric pump infection or complications at the insertion site
History of drug abuse that might interfere with study participation
Any condition that the study doctor believes would make participation unsafe

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

Site Name	City	Country	Status
Region Vaestmanland	Vasteras	Sweden

Other Sites

No sites found in this category

Trial status

Country	Status	Recruitment Start
Sweden	Recruiting	06.10.2025

Trial locations

Investigated drugs:

Cloxacillin Sodium

Cloxacillin is an antibiotic medication that belongs to the penicillin family. It is used to treat various bacterial infections, particularly those caused by certain types of Staphylococcus bacteria. In this study, the medication is administered through a special device called an elastomeric pump, which delivers the medicine continuously into the bloodstream. This method of delivery is different from traditional intermittent dosing and may help maintain steady levels of the antibiotic in the body.

The elastomeric pump is a small, portable device that uses an elastic balloon-like container to deliver medication at a constant rate through a thin tube connected to the patient’s vein.

Staphylococcus aureus infection – A bacterial infection caused by the Staphylococcus aureus organism, which can affect various parts of the body. The bacteria can live harmlessly on many skin surfaces, but when they enter the body through a cut or other wound, they can cause an infection. The infection typically begins with redness, swelling, and warmth in the affected area. S. aureus can cause a range of infections, from minor skin problems to infections in deeper tissues. The bacteria can spread through direct contact with an infected person or by touching contaminated objects or surfaces.

Trial ID:

2023-510423-30-00

NCT ID:

NCT06848387

Trial Phase:

Therapeutic confirmatory (Phase III)

Other Trials to Consider

#1 Clinical Trials Search in Europe

Study of Continuous Infusion of Cloxacillin Using Elastomeric Pump in Adult Patients with Staphylococcus Aureus Infection

What is this study about?

Who Can Join the Study?

Who Cannot Join the Study?